Robert Tweyongyere

Robert Tweyongyere

Auto-generated profile, based on publicly available information

Robert Tweyongyere

College of Veterinary Medicine, Animal Resources and Biosecurity (CoVAB), Makerere University, Kampala, Uganda

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2013 in BMC Public Health
Verified
Journal Article
Open access
PDF file
DKDennison Kizito
Dennison Kizito
RTRobert Tweyongyere
Robert Tweyongyere
ANAlice Namatovu
Alice Namatovu
EWEmily L Webb
Emily L Webb
LMLawrence Muhangi
Lawrence Muhangi
AEAlison M Elliott
Alison M Elliott
Vaccine failure is an important concern in the tropics with many contributing elements. Among them, it has been suggested that exposure to natural infections might contribute to vaccine failure and recurrent disease outbreaks. We tested this hypothesis by examining the influence of co-infections on maternal and infant measles-specific IgG levels. We conducted an observational analysis using samples and data that had been collected during a larger randomised controlled trial, the Entebbe Mother and Baby Study (ISRCTN32849447). For the present study, 711 pregnant women and their offspring were considered. Helminth infections including hookworm, Schistosoma mansoni and Mansonella perstans, along with HIV, malaria, and other potential confounding factors were determined in mothers during pregnancy and in their infants at age one year. Infants received their measles immunisation at age nine months. Levels of total IgG against measles were measured in mothers during pregnancy and at delivery, as well as in cord blood and from infants at age one year. Among the 711 pregnant women studied, 66% had at least one helminth infection at enrolment, 41% had hookworm, 20% M. perstans and 19% S. mansoni. Asymptomatic malaria and HIV prevalence was 8% and 10% respectively. At enrolment, 96% of the women had measles-specific IgG levels considered protective (median 4274 mIU/ml (IQR 1784, 7767)). IgG levels in cord blood were positively correlated to maternal measles-specific IgG levels at delivery (r = 0.81, p < 0.0001). Among the infants at one year of age, median measles-specific IgG levels were markedly lower than in maternal and cord blood (median 370 mIU/ml (IQR 198, 656) p < 0.0001). In addition, only 75% of the infants had measles-specific IgG levels considered to be protective. In a multivariate regression analysis, factors associated with reduced measles-specific antibody levels in infancy were maternal malaria infection, infant malaria parasitaemia, infant HIV and infant wasting. There was no association with maternal helminth infection. Malaria and HIV infection in mothers during pregnancy, and in their infants, along with infant malnutrition, may result in reduction of the antibody response to measles immunisation in infancy. This re-emphasises the importance of malaria and HIV control, and support for infant nutrition, as these interventions may have benefits for vaccine efficacy in tropical settings.

12 May 2020 in Journal of Nanoparticle Research
Verified
Journal Article
Closed access
PDF file
KSKenneth Ssekatawa
Kenneth Ssekatawa
DBDennis K. Byarugaba
Dennis K. Byarugaba
CKCharles D. Kato
Charles D. Kato
FEFrancis Ejobi
Francis Ejobi
RTRobert Tweyongyere
Robert Tweyongyere
EWEddie Wampande
Eddie Wampande

13 September 2022 in Journal of Infection
Verified
Journal Article
Open access
SAStella A. Atim
Stella A. Atim
SAShirin Ashraf
Shirin Ashraf
SBSandra Belij-Rammerstorfer
Sandra Belij-Rammerstorfer
AAAnna R Ademun
Anna R Ademun
PVPatrick Vudriko
Patrick Vudriko
RTRobert Tweyongyere
Robert Tweyongyere
Crimean-Congo Haemorrhagic Fever (CCHF) is an emerging human-health threat causing sporadic outbreaks in livestock farming communities. However, the full extent and the risks associated with exposure of such communities has not previously been well-described. We collected blood samples from 800 humans, 666 cattle, 549 goats and 32 dogs in districts within and outside Ugandan cattle corridor in a cross-sectional survey, and tested for CCHFV-specific IgG antibodies using Enzyme-Linked Immunosorbent Assays. Sociodemographic and epidemiological data were recorded using structured questionnaire. Ticks were collected to identify circulating nairoviruses by metagenomic sequencing. CCHFV seropositivity was in 221/800 (27·6%) in humans, 612/666 (91·8%) in cattle, 413/549 (75·2%) in goats and 18/32 (56·2%) in dogs. Human seropositivity was associated with livestock farming (AOR=5·68, p<0·0001), age (AOR=2·99, p=0·002) and collecting/eating engorged ticks (AOR=2·13, p=0·004). In animals, seropositivity was higher in cattle versus goats (AOR=2·58, p50 ticks: AOR=3·52, p=0·004). CCHFV was identified in multiple tick pools of Rhipicephalus appendiculatus. The very high CCHF seropositivity especially among livestock farmers and multiple regional risk factors associated exposures, including collecting/eating engorged ticks previously unrecognised, highlights need for further surveillance and sensitisation and control policies against the disease.

1 September 2018 in Ticks and Tick-borne Diseases
Verified
Journal Article
Closed access
DTDickson Tayebwa
Dickson Tayebwa
PVPatrick Vudriko
Patrick Vudriko
BTBumduuren Tuvshintulga
Bumduuren Tuvshintulga
AGAzirwan Guswanto
Azirwan Guswanto
ANArifin Budiman Budiman Nugraha
Arifin Budiman Budiman Nugraha
Ikuo IgarashiIkuo Igarashi
Ikuo Igarashi

11 January 2021 in Onderstepoort Journal of Veterinary Research
Verified
Journal Article
Open access
PDF file
MEMULABBI NICHOLAS ELIJAH
MULABBI NICHOLAS ELIJAH
RTRobert Tweyongyere
Robert Tweyongyere
DBDenis K. Byarugaba
Denis K. Byarugaba
Human coronaviruses are known respiratory pathogens associated with a range of respiratory illnesses, and there are considerable morbidity and hospitalisation amongst immune-compromised individuals of all age groups. The emergence of a highly pathogenic human coronavirus in China in 2019 has confirmed the long-held opinion that these viruses are important emerging and re-emerging pathogens. In this review article, we trace the discovery and emergence of coronaviruses (CoVs) over time since they were first reported. The review article will enrich our understanding on the host range, diversity and evolution, transmission of human CoVs and the threat posed by these viruses circulating in animal populations but overtime have spilled over to humans because of the increased proximity between humans and animals.

14 February 2019 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
RTRobert Tweyongyere
Robert Tweyongyere
BNBeatrice R. Nassanga
Beatrice R. Nassanga
AMAllan Muhwezi
Allan Muhwezi
MOMatthew Odongo
Matthew Odongo
SLSwaib A. Lule
Swaib A. Lule
AEAlison M Elliott
Alison M Elliott
Schistosoma infection is associated with immune modulation that can influence responses to non-schistosome antigens. Vaccine responses may be impaired in S. mansoni-infected individuals. We investigated effects of S. mansoni infection on responses to childhood measles catch-up immunisation and of praziquantel treatment on this outcome in a randomised trial. The Immune Modulation and Childhood Immunisation (IMoChI) study was based in Entebbe, Uganda. Children aged 3–5 years (193 S. mansoni-infected and 61 uninfected) were enrolled. Infected children were randomised in a 1:1:1 ratio to receive praziquantel 2 weeks before, at time of, or 1 week after, measles catch-up immunisation. Plasma anti-measles IgG was measured at enrolment, 1 week and 24 weeks after measles immunisation. Primary outcomes were IgG levels and percentage of participants with levels considered protective against measles. Anti-measles IgG levels increased following immunisation, but at 1 week post-immunisation S. mansoni-infected, compared to uninfected, children had lower levels of anti-measles IgG (adjusted geometric mean ratio (aGMR) 0.4 [95% CI 0.2–0.7]) and the percentage with protective antibody levels was also lower (adjusted odds ratio 0.1 [0–0.9]). Among S. mansoni-infected children, anti-measles IgG one week post-immunisation was higher among those treated with praziquantel than among those who were not yet treated (treatment before immunisation, aGMR 2.3 [1.5–4.8]; treatment at immunisation aGMR 1.8 [1.1–3.5]). At 24 weeks post-immunisation, IgG levels did not differ between the trial groups, but tended to be lower among previously-infected children who were still S mansoni stool-positive than among those who became stool-negative. Our findings suggest that S. mansoni infection among pre-school children is associated with a reduced antibody response to catch-up measles immunisation, and that praziquantel treatment improves the response. S. mansoni infection may contribute to impaired vaccine responses in endemic populations; effective schistosomiasis control may be beneficial for vaccine efficacy. This should be further explored. ISRCTN87107592. Infection with the blood fluke Schistosoma mansoni, which causes Bilharzia, is common among communities living along the shores of Lake Victoria in Uganda and elsewhere around fresh water bodies in Africa. Infection with this parasite is known to alter the body’s immune responses, even to stimuli which are not directly related to the parasite. This alteration may have an adverse impact on responses to vaccines. However, there is still insufficient information on such effects and on whether treatment of schistosomiasis can reverse them. We conducted a study on the Entebbe peninsula in Lake Victoria to examine the effects of infection with S. mansoni parasites on responses to childhood measles catch-up immunisation, and the effect of treating the parasites on the responses. A cohort of 3–5 year-old children, either infected with S. mansoni or not, was enrolled and given measles immunisation. The infected children were treated for S. mansoni either before, at the time of, or a week after the immunisation. Levels of antibodies against measles were measured at one week and 24 weeks after immunisation as indicator of possible protection against measles. The levels of antibodies against measles were lower among the S mansoni-infected children than the uninfected children, and treatment improved this situation. This implies that S. mansoni infection is associated with reduced measles immunisation responses and that treatment improves the response. At 24 weeks post-immunisation, when all children had been treated for S. mansoni, at least 95% of children in all groups had protective levels of antibody. Considering that pre-school children are vulnerable to Bilharzia, an effective schistosomiasis control programme that includes this age group may be beneficial for vaccine efficacy, an issue that needs further investigation.